| A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. (NCT01672645) | Pfizer | 2012-06-01 |
| Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke (NCT01714167) | Wenzhou Medical University | 2012-06-01 |
| Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment (NCT01596530) | AstraZeneca | 2012-06-01 |
| A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K (NCT01686217) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| Dexanabinol in Patients With Brain Cancer (NCT01654497) | Santosh Kesari, M.D., Ph.D. | 2012-06-01 |
| Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) (NCT01700335) | SymBio Pharmaceuticals | 2012-06-01 |
| Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer (NCT01594918) | Rahul Aggarwal | 2012-06-01 |
| Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination (NCT01559831) | Valneva Austria GmbH | 2012-06-01 |
| A Safety Evaluation of Renal Denervation Using Focused Therapeutic Ultrasound on Patients With Refractory Hypertension (NCT01638195) | Kona Medical Inc. | 2012-06-01 |
| Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults (NCT01574638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers (NCT01631422) | Hoffmann-La Roche | 2012-06-01 |
| Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain (NCT01659372) | Shahid Beheshti University | 2012-06-01 |
| the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake (NCT01873014) | Tianjin Medical University Cancer Institute and Hospital | 2012-06-01 |
| Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease (NCT02445547) | Fuzhou General Hospital | 2012-06-01 |
| A Safety Evaluation of the Use of Magnetic-guided Iron Particles (NCT01519076) | Pulse Therapeutics | 2012-06-01 |
| A Multiple-dose Study of LY3031207 in Healthy Participants (NCT01632566) | Eli Lilly and Company | 2012-06-01 |
| Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition (NCT01735318) | IPCA Laboratories Ltd. | 2012-06-01 |
| Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents (NCT01609998) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 (NCT01621217) | Lund University Hospital | 2012-06-01 |
| Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion (NCT01635972) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia (NCT01606436) | Denovo Biopharma LLC | 2012-06-01 |
| Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects (NCT01619345) | Novo Nordisk A/S | 2012-06-01 |
| Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple Sclerosis (NCT01712945) | Cambridge University Hospitals NHS Foundation Trust | 2012-06-01 |
| Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer (NCT01605916) | AstraZeneca | 2012-06-01 |
| A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) (NCT01583647) | Merck Sharp & Dohme LLC | 2012-06-01 |
| A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Participants (NCT01626651) | Janssen Research & Development, LLC | 2012-06-01 |
| CRLX101 Plus Bevacizumab in Advanced RCC (NCT01625936) | Abramson Cancer Center at Penn Medicine | 2012-06-01 |
| Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome (NCT01578720) | Retina Research Institute, LLC | 2012-06-01 |
| Food Effect Study of Single Dose of Fruquintinib (HMPL-013) in Healthy Subjects (NCT01955304) | Hutchison Medipharma Limited | 2012-06-01 |
| A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects (NCT01616277) | Pfizer | 2012-06-01 |
| Norepinephrine Transporter Availability in PTSD (NCT01799837) | Emory University | 2012-06-01 |
| Evaluation of the Bioequivalence of a Combined Formulated Tablet (NCT01622790) | ViiV Healthcare | 2012-06-01 |
| Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition (NCT01735344) | IPCA Laboratories Ltd. | 2012-06-01 |
| Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota. (NCT01897649) | Nealth Sarl | 2012-06-01 |
| Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis (NCT01333228) | Clinica Universidad de Navarra, Universidad de Navarra | 2012-06-01 |
| Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke (NCT03296618) | Suzhou Neuralstem Biopharmaceuticals | 2012-06-01 |
| Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD) (NCT01632527) | StemCells, Inc. | 2012-06-01 |
| A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients (NCT01656525) | Chugai Pharmaceutical | 2012-06-01 |
| An Adaptive Treatment Strategy for Adolescent Depression-Continuation (NCT02017535) | University of Minnesota | 2012-06-01 |
| Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia (NCT01968486) | University of Campania Luigi Vanvitelli | 2012-06-01 |
| Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT02206204) | Actelion | 2012-06-01 |
| A Study of LY2875358 in Japanese Participants With Advanced Cancer (NCT01602289) | Eli Lilly and Company | 2012-06-01 |
| Varenicline on Reward Responses and Cognition in Adolescent Smokers (NCT01624428) | Yale University | 2012-06-01 |
| Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects (NCT01788696) | Duke University | 2012-06-01 |
| Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma (NCT01639612) | Henry Friedman | 2012-06-01 |
| Effect of Socket Wall Height With Vacuum Suspension for Above Knee Amputees (NCT01559909) | Stony Brook University | 2012-06-01 |
| Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years (NCT01560793) | VaxInnate Corporation | 2012-06-01 |
| Open-Label Pharmacokinetic Study of Final Formulations of ATX-101 (NCT01632917) | Kythera Biopharmaceuticals | 2012-06-01 |
| Naloxone Nasal Spray Pharmacokinetic Study (NCT01622504) | Mitovie Pharma Ltd | 2012-06-01 |
| Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults (NCT01624961) | Sanaria Inc. | 2012-06-01 |
| Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. (NCT01637636) | Vanda Pharmaceuticals | 2012-06-01 |
| A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 (NCT01589614) | Pfizer | 2012-06-01 |
| DNA-based Influenza Vaccine in the Elderly (NCT01587131) | University of Manitoba | 2012-06-01 |
| Multiple Antigen-Engineered DC Vaccine for Melanoma (NCT01622933) | Lisa H. Butterfield, Ph.D. | 2012-06-01 |
| Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia (NCT01650272) | Siriraj Hospital | 2012-06-01 |
| Pancreatic Perfusion Using Secretin and MRI (NCT02458118) | University of Nottingham | 2012-06-01 |
| AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia (NCT01655875) | Emory University | 2012-06-01 |
| RBL001/RBL002 Phase I Clinical Trial (NCT01684241) | BioNTech RNA Pharmaceuticals GmbH | 2012-06-01 |
| A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies (NCT01604863) | Human Genome Sciences Inc., a GSK Company | 2012-06-01 |
| Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects (NCT01671020) | Boryung Pharmaceutical Co., Ltd | 2012-06-01 |
| Pharmacokinetic Study of Primaquine and Dihydroartemisinin-Piperaquine in Healthy Subjects (NCT01525511) | University of Oxford | 2012-06-01 |
| Validation Study in Healthy Female Volunteers: A Comparison of Two Neurotech Vital Devices Set up to Provide Different Types of Electrical Stimulation (NCT01632748) | Bio-Medical Research, Ltd. | 2012-06-01 |
| Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant (NCT01491919) | Uptal Patel | 2012-06-01 |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002) (NCT01614782) | Merck Sharp & Dohme LLC | 2012-06-01 |
| Synchrotron Radiation to the Treatment of Intracranial Tumors (NCT01640509) | University Hospital, Grenoble | 2012-06-01 |
| A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers (NCT01612143) | Hoffmann-La Roche | 2012-06-01 |
| Project FARMS: Fall Risk Reduction in Multiple Sclerosis (NCT01837017) | University of Illinois at Urbana-Champaign | 2012-06-01 |
| XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease (NCT01582295) | Massachusetts General Hospital | 2012-06-01 |
| Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors (NCT01634893) | The University of Texas Health Science Center at San Antonio | 2012-06-01 |
| Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition (NCT01722201) | IPCA Laboratories Ltd. | 2012-06-01 |
| Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults (NCT01634412) | Tonix Pharmaceuticals, Inc. | 2012-06-01 |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma (NCT01378481) | National Cancer Institute (NCI) | 2012-06-01 |
| Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis (NCT01946984) | Specialized Arab Hospital | 2012-06-01 |
| Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients (NCT01559103) | Novo Nordisk A/S | 2012-05-31 |
| Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma (NCT01480050) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-05-31 |
| Administration of IV Laronidase Post Bone Marrow Transplant in Hurler (NCT01173016) | Masonic Cancer Center, University of Minnesota | 2012-05-29 |
| A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors (NCT01543698) | Pfizer | 2012-05-28 |
| A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients (NCT01586325) | Janssen R&D Ireland | 2012-05-25 |
| A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (NCT01262664) | M.D. Anderson Cancer Center | 2012-05-24 |
| H5N1 Vaccination With and Without AS03: Systems Biology Analysis (NCT01573312) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-24 |
| Phase I Trial of a Single Dose of CRS3123 (NCT01551004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-22 |
| A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT01594229) | AbbVie | 2012-05-21 |
| Nutrition, Exercise, and Wellness Treatment (NEW Tx) for Bipolar Disorder (NCT01615367) | Massachusetts General Hospital | 2012-05-21 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235. (NCT01607385) | GlaxoSmithKline | 2012-05-18 |
| Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs (NCT01590199) | Novartis Pharmaceuticals | 2012-05-18 |
| A Phase 1, Open-Label, 10 Day Safety Study (NCT01623401) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-05-17 |
| Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive) (NCT01544166) | Bayer | 2012-05-16 |
| CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII (NCT01454596) | National Cancer Institute (NCI) | 2012-05-16 |
| Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers (NCT01673555) | GlaxoSmithKline | 2012-05-15 |
| Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01246063) | Washington University School of Medicine | 2012-05-14 |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer (NCT01582191) | M.D. Anderson Cancer Center | 2012-05-14 |
| A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease (NCT01597401) | Baxalta now part of Shire | 2012-05-12 |
| A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors (NCT01582997) | GlaxoSmithKline | 2012-05-11 |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma (NCT01610570) | National Cancer Institute (NCI) | 2012-05-10 |
| The Pharmacokinetic Interaction Between Celecoxib and Rebamipide (NCT01549743) | Hanlim Pharm. Co., Ltd. | 2012-05-09 |
| AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer (NCT01597388) | AstraZeneca | 2012-05-08 |
| A Single Rising Dose Study of MK-8150 (MK-8150-001) (NCT01590810) | Merck Sharp & Dohme LLC | 2012-05-07 |
| In Vivo Lithium Treatment Effects on Gene Expression Levels in Lymphoblastoid Cell Lines From Human Healthy Subjects (NCT01565759) | Nova Scotia Health Authority | 2012-05-05 |
| CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer (NCT01583686) | National Cancer Institute (NCI) | 2012-05-04 |
| Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs (NCT01387594) | Shire | 2012-05-03 |